ArticleBMC musculoskeletal disorders2019

Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren's disease -derived fibroblasts.

Chaoming Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.